| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pediatrics (B.M.K.) and Internal Medicine (B.M.K., A.R.Z.) and McDermott Center for Human Growth and Development (B.M.K., J.L.H., K.P.T., T.G., A.R.Z.), The University of Texas Southwestern Medical School, Dallas, Texas 75390-8591
Address all correspondence and requests for reprints to: Bassil Kublaoui, Departments of Pediatrics and Internal Medicine and McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8591. E-mail: bassil.kublaoui{at}utsouthwestern.edu; or andrew.zinn{at}utsouthwestern.edu.
Single-minded 1 (SIM1) mutations are associated with obesity in mice and humans. Haploinsufficiency of mouse Sim1 causes hyperphagic obesity with increased linear growth and enhanced sensitivity to a high-fat diet, a phenotype similar to that of agouti yellow and melanocortin 4 receptor knockout mice. To investigate the effects of increased Sim1 dosage, we generated transgenic mice that overexpress human SIM1 and examined their phenotype. Compared with wild-type mice, SIM1 transgenic mice had no obvious phenotype on a low-fat chow diet but were resistant to diet-induced obesity on a high-fat diet due to reduced food intake with no change in energy expenditure. The SIM1 transgene also completely rescued the hyperphagia and partially rescued the obesity of agouti yellow mice, in which melanocortin signaling is abrogated. Our results indicate that the melanocortin 4 receptor signals through Sim1 or its transcriptional targets in controlling food intake but not energy expenditure.
This article has been cited by other articles:
![]() |
B. M. Kublaoui, T. Gemelli, K. P. Tolson, Y. Wang, and A. R. Zinn Oxytocin Deficiency Mediates Hyperphagic Obesity of Sim1 Haploinsufficient Mice Mol. Endocrinol., July 1, 2008; 22(7): 1723 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wu, M. P. Howell, M. A. Cowley, and R. D. Palmiter Starvation after AgRP neuron ablation is independent of melanocortin signaling PNAS, February 19, 2008; 105(7): 2687 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Foster-Schubert and D. E. Cummings Emerging Therapeutic Strategies for Obesity Endocr. Rev., December 1, 2006; 27(7): 779 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Baskin Single-minded view of melanocortin signaling in energy homeostasis. Endocrinology, October 1, 2006; 147(10): 4539 - 4541. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |